Skip to main content
OpenTrials
Completed

NCT Number: NCT06113874

The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration

This study aims to investigate the influence of desensitizing agents on reducing post-operative sensitivity in posterior composite.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dentin Hypersensitivity Dentin Sensitivity Stomatognathic Diseases Tooth Diseases

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry, Alexandria University

Alexandria, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients having active primary class I carious lesions on vital molar teeth either in the middle or the inner third of dentin in the three quadrants of each patients.
  • Teeth having a positive reaction to vitality test (cold test), no signs of pulp inflammation, or spontaneous pain before treatment.
  • Preoperative radiographic record of the carious lesions.
  • Buccolingual width is no more than half the inter-cuspal distance

Exclusion criteria

  • Excessive tooth wear due to clenching or abnormal habits.
  • Patients with direct occlusal contact by antagonist cusp (traumatic occlusion).
  • Patients with periodontal or gingival disease.
  • Patients using analgesics and/or anti-inflammatory medicine.

Treatment and study plan

Hurriseal desensitizer

Other

Patients will receive Hurriseal desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Gluma desensitizer

Other

Patients will receive Gluma desensitizing agent and universal bond and composite.

Cavities will be restored with light-cured composite resin following the application of bonding agent.

Primary outcomes

  1. Hypersensitivity assessment

    Time frame: up to 12 months

    Air spray will be applied from a 2-mm distance on to the occlusal for 3 seconds. The severity of patients' pain/sensitivity will be recorded using (0-10) numerical rating scale. The score will be ranged from 0 (No pain) to 10 (maximum pain)

Sponsors and collaborators

Lead sponsor

Nourhan M.Aly

Other

Registry information

Official study title

The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration: A Randomized Controlled Clinical Trial

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Nov 2, 2023
Registry last updated
Nov 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.